AI-generated summary
In this proof-of-concept study in rats, the authors applied photobiomodulation therapy after experimental myocardial infarction and measured gene and microRNA expression in heart tissue over time up to 3 days. The authors report that the therapy reversed changes in extracellular matrix gene expression induced by the infarction and altered microRNAs linked to fibrosis, suggesting an effect on cardiac fibrosis activation.
- Who or what was studied
- Rats with experimentally induced myocardial infarction
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract describes a proof-of-concept animal study and reports correlations rather than causal effects, without stated human data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 22.5 J/cm2, 1.1 J/cm2
- Power
- 15 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Wavelength, Fluence, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.